Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Betamethasone dipropionate reduced skin thickness, fish oil increased it, and combined treatment had no significant effect.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Frailer men have a higher risk of worsening prostate problems and serious health events needing hospital care.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

Acne and hair loss in women can greatly lower their quality of life, but having polycystic ovarian syndrome does not.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Tofacitinib may help regrow hair in alopecia areata patients.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Probiotics may help improve symptoms in rheumatoid arthritis patients.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Many lupus patients experience hair loss, which is linked to anxiety and other skin issues.

Psoriasis is linked to a higher risk of autoimmune diseases and other health conditions.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.